Unknown

Dataset Information

0

Tenofovir: What We Have Learnt After 7.5 Million Person-Years of Use.


ABSTRACT: Tenofovir was licensed for use in patients with HIV in 2001 and since then has become a firmly established anti-retroviral in both guidelines and routine practice. Data have been presented from many pivotal studies-informing on its efficacy, use, and adverse features-and there are also over 7.5 million patient-years of experience to date. We explore the data on this nucleotide reverse transcriptase inhibitor in HIV presented since 2008-focusing on efficacy, side effects, and utility.

SUBMITTER: Ustianowski A 

PROVIDER: S-EPMC4471058 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6759906 | biostudies-other
| S-EPMC8564244 | biostudies-literature
| S-EPMC3834737 | biostudies-literature
| S-EPMC5814403 | biostudies-literature
| S-EPMC3719431 | biostudies-other
| S-EPMC4763753 | biostudies-other
| S-EPMC6760583 | biostudies-literature
| S-EPMC6300913 | biostudies-literature
2019-12-12 | GSE134707 | GEO
| S-EPMC1838446 | biostudies-literature